In The News

09.30.17

Uncertainty Follows Oklahoma’s Withdrawn 1332 Waiver

Manatt’s Joel Ario, a managing director with Manatt Health, spoke with NewsOK on Oklahoma’s withdrawn 1332 reinsurance waiver application. The waiver would have given the state permission to use $350 million in federal funds that would act as a backstop by paying a certain percentage of ...


09.29.17

CMS Fails to Approve Oklahoma’s 1332 Waiver on Time

Inside Health Policy quoted Manatt’s Joel Ario, a managing director with Manatt Health, on Oklahoma’s recent withdrawal of its 1332 reinsurance waiver application. The publication noted that the wavier would have helped 130,000 residents by reducing premiums by approximately 34 percent, ...


09.27.17

Skelos Ruling Gives Post-McDonnell Insight

In a recent Law360 article, Manatt’s Richard Hartunian, a partner in the firm’s corporate investigation and white collar defense practice, discussed the recent Second Circuit decision to vacate convictions of ex-New York lawmaker Dean Skelos. According to the publication, this ruling ...


09.26.17

Flexibility Without Funding Is a ‘Hollow Promise’ for States

Manatt’s Patricia Boozang, a senior managing director with Manatt Health, was interviewed by BYU Radio on the potential impacts of state-based healthcare.Boozang explained that under the Affordable Care Act, most states would have welcomed more flexibility and autonomy in their relationships ...


09.25.17

Manatt Leads Rosco, Inc. to Patent Infringement Settlement

Manatt represented Rosco, Inc. in a patent infringement suit against its competitor Rostra Precision Controls, Inc. in the United States District Court, Southern District of New York.   Rosco is one of North America’s leading suppliers of backup camera systems, mirrors and visors to ...


09.25.17

The Theory of Implied Certification Post-Escobar

Manatt’s Jacqueline Wolff, co-chair of the firm’s corporate investigations and white collar defense practice, was interviewed by Health Law Daily for an article on implied certification in cases since Universal Health Services, Inc. v. U.S. ex rel. Escobar.The publication notes that in ...


09.25.17

Manatt Health’s Cindy Mann Testifies at Senate Finance Committee Hearing on Graham-Cassidy

Discussion Sets the Stage for the Future of Healthcare Reform in 2017Manatt partner Cindy Mann, who has over 30 years of federal- and state-level experience in health policy, today testified in opposition to Graham-Cassidy at the United States Senate Committee on Finance’s hearing to consider ...


09.25.17

Failed ACA Repeal Efforts Could Indicate a Pause

Manatt’s Joel Ario, a managing director with Manatt Health, was quoted by Law360 in an article discussing the latest Affordable Care Act repeal efforts.Law360 noted that the Senate’s failure to move the Graham-Cassidy bill forward will likely result in pausing similar efforts for the ...


09.21.17

How Some States Could Benefit From Graham-Cassidy

The Hill quoted Manatt’s Jocelyn Guyer, a managing director with Manatt Health, in an article analyzing how the new Affordable Care Act repeal and replace legislation could financially impact various states.The publication explained that states with lower healthcare costs could see funding ...


09.20.17

Manatt Named a Finalist for 2017 M&A Advisor Awards

The M&A Advisor, a preeminent organization focused on offering insights and intelligence on mergers and acquisitions, has named Manatt a finalist for its 16th annual M&A Awards. The awards recognize the leading M&A transactions, restructurings, deal financings, product/services, firms ...